CBD Reversed Memory Problems and Brain Cell Damage in a Mouse Model of Schizophrenia

What the researchers found

Chronic MK-801 treatment (an NMDA receptor blocker) caused memory deficits and reduced gamma brain wave power in mice. Seven days of CBD treatment (30 mg/kg) reversed both the cognitive impairment and the gamma oscillation changes. CBD also restored depleted parvalbumin neurons and their protective perineuronal nets in the prefrontal cortex and hippocampus, and reversed microglia activation in both regions.

Why it matters

Parvalbumin neuron loss and neuroinflammation are hallmarks of schizophrenia. This study maps out specific receptor pathways through which CBD appears to reverse these changes, providing a mechanistic foundation for understanding how CBD might address cognitive symptoms that current antipsychotics often fail to treat.

The numbers in context

CBD dose: 30 mg/kg daily for 7 days. MK-801 dose: 0.5 mg/kg twice daily for 14 days. CBD's cognitive effects were blocked by a 5-HT1A antagonist but not a CB2 antagonist. Neuroprotective effects in the hippocampus required both 5-HT1A and CB2 receptors, while prefrontal effects were independent of both.

How the study worked

Animal study using chronic MK-801 administration (0.5 mg/kg twice daily for 14 days) to model schizophrenia-like symptoms in mice. CBD (30 mg/kg daily for 7 days) was given after the MK-801 treatment period. Receptor antagonists were used to identify which receptors mediated CBD's effects. Brain regions examined: prelimbic medial prefrontal cortex and ventral hippocampus.

What this study cannot tell us

Animal study; results may not translate to humans. MK-801 model captures some but not all aspects of schizophrenia. Single CBD dose tested. Short treatment duration. No assessment of long-term effects.

How to read the evidence

Preliminary: animal study with detailed mechanistic findings, but no human data.

When this study was published

Published in 2025.

The bigger picture

Current antipsychotic medications primarily target positive symptoms of schizophrenia (hallucinations, delusions) but do little for cognitive deficits. CBD's ability to reverse memory impairment and restore damaged brain cells in this model suggests a potential complementary approach, though the leap from mouse models to human treatment remains substantial.

Questions still open

• Would CBD show similar neuroprotective effects in humans with schizophrenia?
• What is the optimal CBD dosing for cognitive symptoms?
• Could CBD be combined with existing antipsychotics safely?

Common questions

Read the original research

Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia.

Brain research, 1863, 149772

Citation

Rodrigues da Silva, Naielly; Gobbo, Davide; Gomes, Felipe V; Scheller, Anja; Kirchhoff, Frank; Del Bel, Elaine; Silveira Guimarães, Francisco. (2025). Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia.. Brain research, 1863, 149772. https://doi.org/10.1016/j.brainres.2025.149772

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk